Browsing by Author "Janson, J."

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Atrialised right ventricular myxoma in a patient with Ebstein’s anomaly
    (BioScientifica, 2018) John, T. J.; Snyman, H. W.; Janson, J.; Pecoraro, A. J. K.
    Ebstein’s anomaly is a rare entity affecting around 1 in 200,000 live births and accounts for less than 1% of congenital heart diseases. Ebstein’s anomaly with an associated right-sided myxoma is extremely rare, with only one other case report found in the literature. Previous reports have also noted cases of Ebstein’s anomaly associated with left-sided myxomas. We describe a female patient with, to our knowledge, the first case of a histopathologically confirmed right ventricular myxoma in the setting of Ebstein’s anomaly.
  • Thumbnail Image
    Item
    Costs and process of in-patient tuberculosis management at a central academic hospital, Cape Town, South Africa
    (IUATLD -- International Union Against Tuberculosis and Lung Disease, 2012-09) Janson, J.; Marais, Frederick; Mehtar, Shaheen; Baltussen, R. M. P. M.
    Setting: South Africa reports more cases of tuberculosis (TB) than any other country, but an up-to-date, precise estimate of the costs associated with diagnosing, treating and preventing TB at the in-patient level is not available. Objective: To determine the costs associated with TB management among in-patients and to study the use of personal protective equipment (PPE) at a central academic hospital in Cape Town. Design: Retrospective and partly prospective cost analysis of TB cases diagnosed between May 2008 and October 2009. Results: The average daily in-patient costs were US$238; the average length of stay was 9.7 days. Mean laboratory and medication costs per stay were respectively US$26.82 and US$8.68. PPE use per day cost US$0.99. The average total TB management costs were US$2373 per patient. PPE was not always properly used. Discussion: The costs of in-patient TB management are high compared to community-based treatment; the main reason for the high costs is the high number of in-patient days. An efficiency assessment is needed to reduce costs. Cost reduction per TB case prevented was approximately US$2373 per case. PPE use accounted for the lowest costs. Training is needed to improve PPE use.